Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-06-015127

Chief Financial Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2006-10-30 Exercise or conversion : show line 1 in the form +3,500 $1.10 $3,850 62,081 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2006-10-30 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −3,500 $1.10 2014-02-25 3,500 237,919 D
Loading xslF345X02/doc1.xml…